TIM
CYTK icon

Thornburg Investment Management’s Cytokinetics CYTK Stock Holding History

Thornburg Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Sell
31,133
-52,057
-63% -$3.74M 0.03% 110
2026
Q1 		$5.48M Buy
83,190
+792
+1% +$50.3K 0.06% 103
2025
Q4 		$5.24M Sell
82,398
-2,321
-3% -$144K 0.07% 125
2025
Q3 		$4.66M Buy
84,719
+11,840
+16% +$488K 0.06% 129
2025
Q2 		$2.41M Sell
72,879
-188,014
-72% -$6.54M 0.03% 149
2025
Q1 		$10.5M Sell
260,893
-20,969
-7% -$964K 0.15% 87
2024
Q4 		$13.3M Sell
281,862
-1,620
-0.6% -$84.1K 0.18% 86
2024
Q3 		$15M Buy
283,482
+30,671
+12% +$1.71M 0.19% 76
2024
Q2 		$13.7M Buy
252,811
+169,050
+202% +$10.2M 0.19% 78
2024
Q1 		$5.87M Sell
83,761
-1,438
-2% -$111K 0.08% 147
2023
Q4 		$7.11M Sell
85,199
-22,967
-21% -$832K 0.1% 126
2023
Q3 		$3.19M Sell
108,166
-2,831
-3% -$94.3K 0.05% 158
2023
Q2 		$3.62M Buy
110,997
+20,603
+23% +$762K 0.06% 151
2023
Q1 		$3.18M Sell
90,394
-1,087
-1% -$44.3K 0.05% 152
2022
Q4 		$4.19M Buy
91,481
+17,283
+23% +$744K 0.07% 153
2022
Q3 		$3.6M Buy
+74,198
New +$3.57M 0.06% 160

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thornburg Investment Management's CYTK Position: Q2 2026 in Review

Thornburg Investment Management reduced its Cytokinetics (CYTK) stake by 63% in Q2 2026, selling an estimated $3.74M and leaving 31,133 shares worth $2.65M. The position accounts for 0.03% of the portfolio, ranked #110.

Thornburg Investment Management first reported a position in CYTK in Q3 2022 and has held it in 16 quarters since. The position peaked at $15M in Q3 2024. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Thornburg Investment Management held 31,133 shares of Cytokinetics worth $2.65M as of Q2 2026.
  • Thornburg Investment Management sold 52,057 Cytokinetics shares in Q2 2026, an estimated $3.74M.
  • Cytokinetics made up 0.03% of Thornburg Investment Management's portfolio in Q2 2026, its #110 holding.
  • Thornburg Investment Management first reported a position in Cytokinetics in Q3 2022 and has held it in 16 quarters since.
  • Thornburg Investment Management's Cytokinetics position peaked at $15M in Q3 2024.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Thornburg Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.